Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

98.05 +1.01 (+1.04%)
Official Closing Price Updated: 7:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,269,221
Open 97.04
Bid (Size) 97.75 (1)
Ask (Size) 99.80 (2)
Prev. Close 97.04
Today's Range 96.81 - 98.08
52wk Range 93.25 - 124.36
Shares Outstanding 1,750,942,289
Dividend Yield 1.84%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
2 High-Yield Dividend Stocks You Won't Regret Buying Right Now
These two blue-chip dividend stocks offer investors a reliable income stream in a volatile market. 
Via The Motley Fool
Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage
House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year. 
Via Benzinga

Performance

YTD
-10.52%
-10.52%
1 Month
-4.39%
-4.39%
3 Month
-9.69%
-9.69%
6 Month
-1.79%
-1.79%
1 Year
-17.57%
-17.57%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
Via Benzinga
Healthcare Stocks With at Least 30 Years of Dividend Increases
Via MarketBeat
2 Top Dividend Kings to Buy for the Long Haul
Via The Motley Fool
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Via Benzinga
2 Top Dividend Stocks You Can Buy and Hold Forever
Via The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
Via Benzinga
Why The Apple Watch Comes Up Short In Heart Attack Detection… And Other Alternatives
Via Talk Markets
7 Dividend Kings to Buy for an Uncertain Market Environment
Via InvestorPlace
Healthcare Is Lagging But Biotech Offers Good Potential For Value And Trading
Via Talk Markets
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
Via Investor's Business Daily
Abbott's MitraClip Shows Long Term Benefits In Patients With Leaky Heart Valves
Via Benzinga
Data Shows Abbott's TriClip System Superior To Other Medical Therapy In Heart Valve Disorder
Via Benzinga
2 High-Yield Dividend Stocks to Buy in March
Via The Motley Fool
ABBOTT LABORATORIES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Abbott Laboratories - ABT
From Kahn Swick & Foti, LLC
Via Business Wire
1 High-Flying Growth Stock With 19% Upside, According to Wall Street
Via The Motley Fool
Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices
Via Investor's Business Daily
Build Your Wealth by Buying and Holding These 2 Dividend Stocks for at Least 20 Years
Via The Motley Fool
Get a Dividend Every Month With These 3 Healthcare Stocks
Via The Motley Fool
Lucira Stock Jumps over 250% on FDA Approval, Beware Chapter 11
Via MarketBeat
Topics Initial Public Offering
Exposures COVID-19 Product Safety Securities Market
Why Abbott Laboratories Stock Bumped Higher Today
Via The Motley Fool
How Is The Market Feeling About Abbott Laboratories?
Via Benzinga
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.